Halozyme gets FDA approval for Herceptin Hylecta™

World |  News | 0 Comment | 04 Mar, 2019

Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, has announced that Genentech, a member of the Roche Group, has received approval from t...Read more

Glenmark announces presentation of New Subtype Analysis of GBR 830

World |  News | 0 Comment | 04 Mar, 2019

Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-concept study of GBR 830 at the American Academy of Dermatology (AAD) An...Read more

EMA accepts MMA for Hansa Biopharma’s IDEFIRIX

World |  News | 0 Comment | 01 Mar, 2019

Hansa Biopharma AB, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases has declared that the European Medicines Agency (EMA) has accepted the Company's Mar...Read more

IBSA Pharma launches liquid formula for Hypothyroidism

World |  News | 1 Comment | 28 Feb, 2019

IBSA Pharma is a world leader in the treatment of thyroid disease and has a diversified product portfolio of prescription drugs. With products on five continents and in over 80 countries, I...Read more

Bayer completes NDA submission to USFDA for cancer drug darolutamide

World |  News | 0 Comment | 27 Feb, 2019

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. The company has announced the completion of the rolling submission of a New Dr...Read more

Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

World |  News | 0 Comment | 26 Feb, 2019

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in CNS diseases has annou...Read more

Mallinckrodt signs ECP research collaboration treaty with Transimmune AG

World |  News | 0 Comment | 26 Feb, 2019

Mallinckrodt plc, a leading global specialty pharmaceutical company has entered into a research collaboration agreement with Transimmune AG, a company developing novel immunotherapies ...Read more

Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

World |  News | 0 Comment | 25 Feb, 2019

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more

GE to sell Biopharma business for $21.4B to Danaher

World |  News | 0 Comment | 25 Feb, 2019

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration of $21.4 billion, including $21 billion in cash as well as Danaher&rs...Read more

Roche to acquire Spark Therapeutics for $4.3B

World |  News | 0 Comment | 25 Feb, 2019

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction. Thi...Read more

AbbVie, Voyager to develop vectorized antibodies for PD

World |  News | 0 Comment | 25 Feb, 2019

AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases h...Read more

UCB to form a research satellite facility within King’s College London

World |  News | 0 Comment | 22 Feb, 2019

UCB, a global biopharmaceutical company focusing on developing innovative treatments for patients with neurological and immunological conditions, has expanded its global satellite research ...Read more

WHO releases report on Global Health Expenditure

World |  News | 0 Comment | 22 Feb, 2019

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic product (GDP). A new report on global health expenditure from...Read more

Takeda, Microsoft, EURORDIS releases action plan to end the diagnostic odyssey

World |  News | 0 Comment | 21 Feb, 2019

The Global Commission to End the Diagnostic Odyssey for Children , co-chaired by Takeda, Microsoft and EURORDIS-Rare Diseases Europe, an alliance of more than 800 rare disease patient organ...Read more

Quest Diagnostics teams up with Houston Healthcare for enhancement of diagnostic services

World |  News | 0 Comment | 21 Feb, 2019

Quest Diagnostics, the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients...Read more

Labcorp expands therapeutic drug monitoring portfolio for precision medicine

World |  News | 0 Comment | 21 Feb, 2019

LabCorp®, a leading global life sciences company that is deeply integrated in guiding patient care, announced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE™ port...Read more

Merck gets first U.S. Patent for improved CRISPR technology

World |  News | 0 Comment | 20 Feb, 2019

Merck, a leading science and technology company and leader in genome editing, has announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck...Read more

Shimmer launches Verisense wearable sensor platform for clinical trials

World |  News | 0 Comment | 21 Feb, 2019

Shimmer, a global leader in wearable technology for research applications, has announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground up to...Read more